Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Molecular struggle for transcriptional control

Nature Medicine volume 1, pages 525–527 (1995)Cite this article

What DNA interactive ligands, such as antitumour agents and carcinogens, can do is well known, but exactly how they do it has been a mystery until now.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hurley, L.H. DNA and associated targets for drug design. J. med. Chem. 32, 2027–2033 (1989).

    Article  CAS  Google Scholar 

  2. Basu, A.K. & Essigmann, J.M. Site-specifically modified oligodeoxynucleotides as probes for the structural and biological effects of DNA-damaging agents. Chem. Res. Tox. 1, 1–18 (1988).

    Article  CAS  Google Scholar 

  3. MacLeod, M.C., Powell, K.L. & Tran, N. Binding of the transcription factor, Sp1, to non-target sites in DNA modified by benzo[a]pyrene diol epoxide. Carcinogenesis (in the press).

  4. Li, B., Mao, B., Xu, J., Amin, S., Ibanez, V. & Geacintov, N.E. Distortions in stereospecific and site-specific BPDE–DNA adducts. Proc. Am. Assoc. Cancer Res. 35, 111 (1994).

    Google Scholar 

  5. Treiber, D.K., Zhai, X., Jantzen, H. & Essigmann, J.M. Cisplatin–DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). Proc. natn. Acad. Sci. U.S.A. 91, 5672–5674 (1994).

    Article  CAS  Google Scholar 

  6. Brown, S.J., Kellett, P.J. & Lippard, S.J. Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science 261, 603–605 (1993).

    Article  CAS  Google Scholar 

  7. Sun, D. & Hurley, L.H. Cooperative bending of the 21-base-pair repeats of the SV40 viral early promoter by human Sp1. Biochemistry 33, 9578–9587 (1994).

    Article  CAS  Google Scholar 

  8. Ho, S.N., Boyer, S.H., Schreiber, S.L., Danishefsky, S.J. & Crabtree, G.R. Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: A paradigm for the development of transcriptional antagonists. Proc. natn. Acad. Sci. U.S.A. 91, 9203–9207 (1994).

    Article  CAS  Google Scholar 

  9. Walker, S., Murnick, J. & Kahne, D. Structural characterization of a calicheamicin–DNA complex by NMR. J. Am. Chem. Soc. 115, 7954–7961 (1993).

    Article  CAS  Google Scholar 

  10. Dorn, A., Affolter, M., Muller, M., Gehring, W.J. & Leupin, W. Distamycin-induced inhibition of homeodomain–DNA complexes. EMBO J. 11, 279–286 (1992).

    Article  CAS  Google Scholar 

  11. Chiang, S., Welch, J., Rauscher, F.J. & Beerman, T.A. Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA. Biochemistry 33, 7033–7040 (1994).

    Article  CAS  Google Scholar 

  12. Mitscher, L.A. & Shen, L.L. A cooperative quinolone–DNA binding model for DNA gyrase inhibition. in Nucleic Acid Targeted Drug Design (eds Propst, C.L. & Perun, T.J.) 375–421 (Marcel Dekker, Inc., New York, 1992).

    Google Scholar 

  13. Potmesil, M. Camptothcins: From bench research to hospital wards. Cancer Res. 54, 1431–1439 (1994).

    CAS  PubMed  Google Scholar 

  14. Fan, J.-Y., Sun, D., Yu, H., Kerwin, S. & Hurley, L.H. The self-assembly of a quinobenzoxazine–Mg2+ complex on DNA: A new paradigm for the structure of a drug–DNA complex and implications for the structure of the quinolone bacterial gyrase–DNA complex. J. med. Chem. 38, 408–424 (1995).

    Article  CAS  Google Scholar 

  15. Sun, D. & Hurley, L.H. Demonstration of the asymmetric TBP-induced unwinding of the region immediately downstream of the TATA box using the intercalating DNA-reactive drug pluramycin. Proc. Am. Assoc. Cancer Res. 36, 534 (1995).

    Google Scholar 

  16. Adams, E.G., Badiner, G.J. & Bhuyan, B.K. Effects of U-7,184 and several other CC-1065 analogues on cell survival and cell cycle of Chinese hamster ovary cells. Cancer Res. 48, 109–116 (1988).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Drug Dynamics Institute, College of Pharmacy, The University of Texas at Austin, Austin, Texas, 78712, USA

    Douglas Henderson & Laurence H. Hurley

Authors
  1. Douglas Henderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laurence H. Hurley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henderson, D., Hurley, L. Molecular struggle for transcriptional control. Nat Med 1, 525–527 (1995). https://doi.org/10.1038/nm0695-525

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0695-525

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing